A new angle in retinal diseases
What’s new on
Eye On Angiopoietins?
Our September 2022 update brings new content and features including:
Discovering the role of Ang–Tie signalling in retinal vein occlusion
Learning about the role of pericytes in retinal vascular stability
Additional preclinical evidence on inflammation

Ang, angiopoietin; DME, diabetic macular edema; nAMD, neovascular age-related macular degeneration; RVO, retinal vein occlusion; Tie, tyrosine kinase with immunoglobulin-like domains; VEGF, vascular endothelial growth factor.
- Saharinen P, et al. Nat Rev Drug Discov. 2017;16:635–61
- Chakravarthy U, et al. Retina. 2018;38:343–51
- Swaroop A, et al. Annu Rev Genomics Hum Genet. 2009
- Ciulla TA, et al. Ophthalmol Retina. 2020;4:19–308
- Felcht M, et al. J Clin Invest. 2012;122:1991–2005
- Hakanpaa L, et al. Nat Commun. 2015;30;6:5962
- Regula JT, et al. EMBO Molecular Med. 2016;8(11):1265–88
- Huang H, et al. Nat Rev Cancer. 2010;10:575–85
- Klaassen I, et al. Prog Retin Eye Res. 2013;34:19–48
- Bolinger MT, et al. Int J Mol Sci. 2016;17:1498
- Fiedler U, Augustin HG. Trends Immunol. 2006;27:552–8
- Regula JT, et al. EMBO Mol Med. 2019;11:e10666
- Benest AV, et al. PLoS One. 2013;8:e70459
- Chakravarthy U, et al. Presented at ARVO May 2020, Virtual Meeting
- Fiedler U, et al. Nat Med. 2006;12:235–9